UnitedHealth Stock News

UnitedHealth Group Tuesday named former U.S. Food and Drug Administration commissioner Dr. Scott Gottlieb to its board of directors.

UnitedHealth stock (NYSE: UNH) has faced significant pressure this year, creating a potential setup for a major rally.

UnitedHealth Group said on Tuesday former U.S. Food and Drug Administration commissioner Scott Gottlieb has joined the company's board of directors.

--(BUSINESS WIRE)--Dr. Scott Gottlieb, former U.S. Food and Drug Administration (FDA) commissioner, is joining UnitedHealth Group's (NYSE: UNH) Board of Directors, effective immediately. Dr. Gottlieb, 53, served as FDA commissioner from 2017 to 2019, where he became known for promoting transparency, strengthening patient safety and widening consumer choice. He led initiatives to modernize regul...

Palantir's valuation is far above what investors witnessed at the peak of the dot-com bubble. UnitedHealth stock sold off earlier this year amid some operational headwinds.

For the most part, the big hedge funds have been mostly net sellers of stocks in recent quarters.

Bank of America is seeing strong performance in its consumer banking and wealth management segments. UnitedHealth Group's margins are down this year, but are expected to improve in 2026.

UNH has highlighted numerous bold strategies with the aim of driving margin recovery through 2027, mostly through raised premiums along with benefit adjustments and targeted plan exits. Despite the potential top-line impact arising from member base contraction, the management already expects these efforts to deliver a more sustainable/ premium member base. This is aided by the recently confirme...